SCHEMBL26548205

SCHEMBL26548205

C[Si](C)(C)c1ccc(-c2ccc3cc(-c4ccc(-c5ccncc5)nc4)ccc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 7/20 0.43
PDGFRA P16234 7/20 0.43
GAK O14976 1/20 0.41
DYRK1A Q13627 3/20 0.40
MAP4K4 O95819 2/20 0.40
CLK2 P49760 2/20 0.40
ROCK1 Q13464 2/20 0.40
CLK4 Q9HAZ1 2/20 0.40
CDK8 P49336 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40
ACVR1 Q04771 1/20 0.40
LRRK2 Q5S007 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
CLK1 P49759 1/20 0.39
ABL1 P00519 1/20 0.39
CYP19A1 P11511 3/20 0.38
EGFR P00533 1/20 0.38
PIK3CD O00329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548720 0.96 GAK (0.40) PDGFRBPDGFRAGAKDYRK1AMAP4K4
SCHEMBL26548367 0.92 HSD17B1 (0.41) PDGFRBPDGFRACYP19A1CYP17A1CYP11B1
SCHEMBL26549230 0.91 GAK (0.54) PDGFRBPDGFRAGAKDYRK1AMAP4K4
SCHEMBL26548853 0.88 HSD17B1 (0.40) CYP19A1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL26548408 0.86 DYRK1A (0.50) PDGFRBPDGFRAGAKDYRK1AMAP4K4
SCHEMBL26548361 0.86 TDO2 (0.46) CYP11B1CYP11B2
SCHEMBL26548364 0.86 TDO2 (0.46) CYP11B1CYP11B2
SCHEMBL26547987 0.86 DYRK1A (0.50) PDGFRBPDGFRAGAKDYRK1AMAP4K4
SCHEMBL26548365 0.85 TDO2 (0.43) PDGFRBPDGFRAROCK1CDK8ABL1
SCHEMBL26548340 0.85 TDO2 (0.43) PDGFRBPDGFRAROCK1CDK8ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 PDGFRB 4867/4885PDGFRA 4853/4885GAK 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.